How to Buy Crispr Therapeutics Ag Stock
Crispr Therapeutics Ag
CRISPR Therapeutics AG (CRSP) is a biotechnology firm dedicated to pioneering gene-based medicines for severe diseases.
Crispr Therapeutics Ag stock last closed at $57.33, up 9.8% from the previous day, and has decreased 2.95% in one year. It has overperformed other stocks in the Biotechnology industry by 0.18 percentage points. Crispr Therapeutics Ag stock is currently +29.93% from its 52-week low of $44.12, and -26.96% from its 52-week high of $78.48.
There are currently 96.69M CRSP shares outstanding. The market value of CRSP is $5.54B. In the last 24 hours, 2.99M CRSP shares were traded.
How to Buy Crispr Therapeutics Ag Stock
Wondering how to invest in Crispr Therapeutics Ag stock? Here's how.
- Choose where to buy Crispr Therapeutics Ag stock: You need to pick a stock brokerage, but don't worry - we've sifted through dozens of online stock brokerages and apps to help you decide where to buy Crispr Therapeutics Ag stock.
- Sign up for your brokerage account: Sign up for 0% commission trading with the highest-rated brokerage we've found.
- Deposit money your investment account: Pick your payment method and add your details.
- Analyze Crispr Therapeutics Ag stock: The Crispr Therapeutics Ag ticker symbol is CRSP. Is Crispr Therapeutics Ag stock a good investment? Should you buy shares of CRSP? How do CRSP's underlying business fundamentals look? Do top analysts think Crispr Therapeutics Ag is a good buy? Why has CRSP's stock price moved recently? (Hint: Our stock market analysis website can help you understand if CRSP is a good stock to buy).
- Make your CRSP purchase: Decide if you will purchase CRSP shares at the current market price or use a limit order to buy CRSP stock at a specific price.
- Monitor your CRSP investment: Create a watchlist to track your new investment in Crispr Therapeutics Ag stock.
Step 1: Choose where to buy Crispr Therapeutics Ag stock
You need a brokerage account in order to access the NASDAQ market and buy CRSP stock.
Our preferred brokerage: eToro
We believe that eToro is the best online stock brokerage. eToro gives you:
- Invest in stocks with zero commissions: Invest without paying trading commissions.
- Buy fractional shares: Even if you can't afford a full share, you can still invest in the stock.
- Access to global financial markets: From Tech to Energy, New York to Tokyo (for US users, only US stocks are available) — you can fill your portfolio with stocks from the globe's leading stock exchanges.
- Social investing: eToro has a community with more than 20 million users worldwide. Talk to, learn from, and copy the unique crypto portfolios of top investors.
- Security: eToro is a regulated and licensed fintech leader.
- Buy other assets: Such as ETFs and cryptocurrencies.
Get $10 towards your purchase of shares by signing up for an account with eToro now. This offer is only for US users.
Open eToro AccountStep 2: Sign up for your brokerage account
Now that you've selected the best brokerage, you need to fill out some personal information so you can invest in CRSP today.
How to Set Up a New Brokerage Account on eToro
- Click here to get started.eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.
- Provide your personal data to start your new brokerage account.
- Submit your information by clicking the "Create Account" button. Get started with eToro today
Step 3: Deposit money your investment account
Now that you've filled out your info on one of the best stock apps, you need to deposit funds:
Watch the walkthrough below for more details transferring funds into your investment account.
Step 4: Analyze Crispr Therapeutics Ag stock
After you have figured out the best place to buy Crispr Therapeutics Ag stock, it's important to research their stock before you buy, so you actually comprehend the risk as well as the opportunity.
Crispr Therapeutics Ag shares quick numbers
Crispr Therapeutics Ag Due Diligence Checks
WallStreetZen was built to help part-time investors do more accurate fundamental analysis quickly.
You can see all of the due diligence checks on CRSP's stock page.
Is CRSP stock properly valued?
Analysts use a variety of different financial metrics, analyses, models, and charts to gauge CRSP's fair value.
Using relative valuations metrics:
- CRSP may be undervalued based on its P/B ratio of 3.17x, relative to Biotechnology industry P/B ratio of 5.34x
You can access additional valuation research on CRSP's stock here.
CRSP Financials at a glance
Positive Health Checks:
- There are more short-term assets than short-term liabilities on the CRSP balance sheet.
- CRSP has cash burn of 371325000. It has enough cash and short-term investments to cover this for at least one year.
- CRSP has $2.37B in cash and short term investments. This is enough to cover its annual cash burn of $371.33M.
- There are more short-term assets than long-term liabilities on the CRSP balance sheet.
Negative Health Checks:
- CRSP has a relatively high debt to equity ratio of 0.52.
- CRSP profit margin has gone down from -1,229.4% to -3,368.7% in the past year.
- Total CRSP debt is higher than 5 years ago, relative to shareholder equity.
Is it a good time to buy Crispr Therapeutics Ag stock, according to Wall Street analysts?
Out of 5 Equities analysts who research CRSP, the consensus analyst rating on CRSP is a Buy
It's important to note that analyst ratings are not stock recommendations, nor are they financial advice.
You can dive deeper into what analysts are projecting on the Crispr Therapeutics Ag stock forecast page.
CRSP Momentum
CRSP Growth Numbers
Last year, CRSP revenue was $13.39M. During the past 5 year, CRSP's revenue has grown by -56.91% per year. This was slower than the Biotechnology industry average of 24.48%.
Dive into CRSP's earnings and revenue performance here.
Are CRSP executives and large shareholders buying or selling the stock?
In the past year, insiders at CRSP have sold more shares than they have bought.
Naimish Patel, Chief Medical Officer of CRSP, was the latest CRSP insider to sell. They sold $210,577.32 worth of CRSP shares on May 29, 2026.
Learn more about who owns CRSP shares here.
Can I rely on CRSP as an income stream?
No, Crispr Therapeutics Ag doesn't provide an income stream by paying out dividends.
What others are saying about CRSP
One of the biggest reasons eToro is our favorite brokerage is because of its social trading community.
Click below to learn what other traders have to say.
Step 5: Make your CRSP purchase
There are two primary options:
- Market order: A market order is an order to buy or sell a stock at the best possible price.
Market orders are mostly the best for newer investors. - Limit order: A limit order is an order to buy or sell a stock at a specific price (or better).
If you want to ensure you're buying or selling at a specific dollar amount, place a limit order.
Hit the Open button and eToro will place your order.
If you require more info about buying stocks on eToro, watch the how to video below:
Step 6: Monitor your CRSP investment
Now that you own some CRSP shares, you'll want to stay up-to-date on your new investment.
Add CRSP to a watchlist to get notified of important updates regarding your CRSP stock.
CRSP Feed
How to Buy Stock in Crispr Therapeutics Ag
To reiterate, here are the 6 steps to buy Crispr Therapeutics Ag stock:
- Choose where to buy Crispr Therapeutics Ag stock
- Sign up for your brokerage account
- Deposit money your investment account
- Analyze Crispr Therapeutics Ag stock
- Make your CRSP purchase
- Monitor your CRSP investment
If you require a online brokerage, eToro is our favorite option.
Get Started with eToro TodayIf you would like to keep track of your new investment in Crispr Therapeutics Ag, create your watchlist below.
Other Articles You May Enjoy
FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterInformation is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.